Jaime Bartushak - Oct 4, 2022 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Financial Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4
Date filed
10/6/2022, 04:07 PM
Previous filing
Oct 13, 2021
Next filing
Oct 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 60.4K Oct 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300K $0.00 300K Oct 4, 2022 Common Stock 300K $1.25 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 4, 2022 Common Stock 300K $2.04 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Oct 4, 2022 Common Stock 100K $2.00 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 125K Oct 4, 2022 Common Stock 125K $1.01 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Oct 4, 2022 Common Stock 100K $0.67 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 70K Oct 4, 2022 Common Stock 70K $1.62 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 25K Oct 4, 2022 Common Stock 25K $3.45 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 48.3K Oct 4, 2022 Common Stock 48.3K $10.50 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F2 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F4 The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
F5 The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F6 One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, September 4, 2018, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F7 On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.
F8 On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months.